Whole-brain low-intensity pulsed ultrasound therapy markedly improves cognitive dysfunctions in mouse models of dementia - Crucial roles of endothelial nitric oxide synthase

• Published in: Brain stimulation 2018-09, Vol.11 (5), p.959-973
• Main Authors: Eguchi, Kumiko, Shindo, Tomohiko, Ito, Kenta, Ogata, Tsuyoshi, Kurosawa, Ryo, Kagaya, Yuta, Monma, Yuto, Ichijo, Sadamitsu, Kasukabe, Sachie, Miyata, Satoshi, Yoshikawa, Takeo, Yanai, Kazuhiko, Taki, Hirofumi, Kanai, Hiroshi, Osumi, Noriko, Shimokawa, Hiroaki
• Format: Article
• Language: English
• Subjects: Dementia; eNOS; LIPUS
• ISSN: 1935-861X; 1876-4754
• DOI: 10.1016/j.brs.2018.05.012

Therapeutic focused-ultrasound to the hippocampus has been reported to exert neuroprotective effects on dementia. In the present study, we examined whether the whole-brain LIPUS (low-intensity pulsed ultrasound) therapy is effective and safe in 2 mouse models of dementia (vascular dementia, VaD and Alzheimer's disease, AD), and if so, to elucidate the common underlying mechanism(s) involved. We used bilateral carotid artery stenosis (BCAS) model with micro-coils in male C57BL/6 mice as a VaD model and 5XFAD transgenic mice as an AD model. We applied the LIPUS therapy (1.875 MHz, 6.0 kHz, 32cycles) to the whole brain. In both models, the LIPUS therapy markedly ameliorated cognitive impairments (Y-maze test and/or passive avoidance test) associated with improved cerebral blood flow (CBF). Mechanistically, the LIPUS therapy significantly increased CD31-positive endothelial cells and Olig2-positive oligodendrocyte precursor cells (OPCs) in the VaD model, while it reduced Iba-1-positive microglias and amyloid-β (Aβ) plaque in the AD model. In both models, endothelium-related genes were significantly upregulated in RNA-sequencing, and expressions of endothelial nitric oxide synthase (eNOS) and neurotrophins were upregulated in Western blotting. Interestingly, the increases in glia cells and neurotrophin expressions showed significant correlations with eNOS expression. Importantly, these beneficial effects of LIPUS were absent in eNOS-knockout mice. These results indicate that the whole-brain LIPUS is an effective and non-invasive therapy for dementia by activating specific cells corresponding to each pathology, for which eNOS activation plays an important role as a common mechanism. •The whole-brain LIPUS is an effective and safe in two mouse models of dementia.•LIPUS enhanced angio- and OPC-genesis in a mouse model of vascular dementia.•LIPUS enhanced angiogenesis and reduced Aβ in a mouse model of Alzheimer disease.•eNOS plays a key role in the beneficial effects of LIPUS in both mouse models.•LIPUS therapy to the whole brain may be a new strategy for dementia in humans.